alpha-Solanine (20562-02-1)
DOI: https://doi.org/10.22427/NTP-DATA-DTXSID9030707
Publications
Final Study Report Developmental Toxicity Evaluation for Alpha-Solanine (CASRN 20562-02-2) Administered by Gavage to Swiss (CD-1®) Mice on Gestational Days 6-16
Final Study Report Developmental Toxicity Evaluation for Alpha-Solanine (CASRN 20562-02-2) Administered by Gavage to Swiss (CD-1®) Mice on Gestational Days 6-16
Study Data
Other NTP Studies
Prenatal Developmental Toxicity Pilot Study (TRP20002) of Alpha-Solanine (20562-02-1) in Swiss CD-1 Mice Exposed via Gavage
Individual and Summary Data
- Dam Data: Dam Body Weights (17 kB)
- Dam Data: Dam Feed Consumption (16 kB)
- Dam Data: Dam Pregnancy Status (3 kB)
- Dam Data: Dam Water Consumption (16 kB)
- Dam Data: Organ Weights (17 kB)
- Fetal Data: All Malformations (355 kB)
- Fetal Data: All Variations (355 kB)
- Fetal Data: Fetal Body Weights (351 kB)
- Live Litter: All Litter (354 kB)
- Live Litter: Live Litter (355 kB)
Prenatal Developmental Toxicity Study (TER20002) of Alpha-Solanine (20562-02-1) in Swiss CD-1 Mice Exposed via Gavage
Swiss CD-1 Mice Individual and Summary Data
- Dam Data: Dam Body Weights (21 kB)
- Dam Data: Dam Feed Consumption (19 kB)
- Dam Data: Dam Pregnancy Status (3 kB)
- Dam Data: Dam Water Consumption (20 kB)
- Dam Data: Organ Weights (21 kB)
- Fetal Data: All Malformations (475 kB)
- Fetal Data: All Variations (475 kB)
- Fetal Data: Fetal Body Weights (471 kB)
- Live Litter: All Litter (473 kB)
- Live Litter: Live Litter (476 kB)